Norum J, Wist E
Avdelingsoverlege, Kreftavdelingen, Regionsykehuset i Tromsø.
Nord Med. 1992;107(8-9):227-8.
Anal carcinoma affects between 30 and 40 Norwegians every year. The disease is twice as frequent in women as in men. It is usually located in the anal canal only, and is cured by a combination treatment with chemotherapy and radiotherapy. Metastatic anal carcinoma has a poor prognosis. We present two such cases. 5-fluorouracil in combination with cisplatin or mitomycin C can give responses even in advanced cases. Radiotherapy may also be of value. In view of the difference between norwegian clinics in the treatment of anal carcinoma, there would appear to be a need of a Scandinavian or international study based on standardized treatment.
每年有30至40名挪威人罹患肛管癌。该疾病在女性中的发病率是男性的两倍。它通常仅位于肛管,通过化疗和放疗的联合治疗可治愈。转移性肛管癌预后较差。我们展示两例这样的病例。5-氟尿嘧啶联合顺铂或丝裂霉素C即使在晚期病例中也可能产生疗效。放疗也可能有价值。鉴于挪威各诊所治疗肛管癌存在差异,似乎有必要开展一项基于标准化治疗的斯堪的纳维亚或国际研究。